 |
Previous Article | Next Article 
The Journal of Neuroscience, January 15, 2000, 20(2):666-673
SNARE Protein-Dependent Glutamate Release from Astrocytes
Alfonso
Araque,
Nianzhen
Li,
Robert T.
Doyle, and
Philip
G.
Haydon
Laboratory of Cellular Signaling, Department of Zoology and
Genetics, Iowa State University, Ames, Iowa 50011
 |
ABSTRACT |
We investigated the cellular mechanisms underlying the
Ca2+-dependent release of glutamate from cultured
astrocytes isolated from rat hippocampus. Using Ca2+
imaging and electrophysiological techniques, we analyzed the effects of
disrupting astrocytic vesicle proteins on the ability of astrocytes to
release glutamate and to cause neuronal electrophysiological responses,
i.e., a slow inward current (SIC) and/or an increase in the frequency
of miniature synaptic currents. We found that the
Ca2+-dependent glutamate release from astrocytes is
not caused by the reverse operation of glutamate transporters, because
the astrocyte-induced glutamate-mediated responses in neurons were
affected neither by inhibitors of glutamate transporters
( -threo-hydroxyaspartate, dihydrokainate, and
L-trans-pyrrolidine-2,4-dicarboxylate) nor by replacement of extracellular sodium with lithium. We show that Ca2+-dependent glutamate release from astrocytes
requires an electrochemical gradient necessary for glutamate uptake in
vesicles, because bafilomycin A1, a vacuolar-type
H+-ATPase inhibitor, reduced glutamate release from
astrocytes. Injection of astrocytes with the light chain of the
neurotoxin Botulinum B that selectively cleaves the vesicle-associated
SNARE protein synaptobrevin inhibited the astrocyte-induced glutamate response in neurons. Therefore, the Ca2+-dependent
glutamate release from astrocytes is a SNARE protein-dependent process
that requires the presence of functional vesicle-associated proteins,
suggesting that astrocytes store glutamate in vesicles and that it is
released through an exocytotic pathway.
Key words:
astrocyte-neuron signaling; astrocyte calcium waves; transmitter release; Botulinum neurotoxin; bafilomycin; exocytosis; SNARE protein; V-ATPase
 |
INTRODUCTION |
Recent evidence suggests that
astrocytes are involved in the active control of neuronal activity and
synaptic transmission. Astrocytes can respond to neuronal activity with
increased intracellular Ca2+ (Dani et al.,
1992 ; Porter and McCarthy, 1996 ; Pasti et al., 1997 ) that can propagate
to neighboring astrocytes as a Ca2+ wave
(Cornell-Bell et al., 1990 ; Charles et al., 1991 ; Newman and Zahs,
1997 ). Furthermore, an elevation of astrocyte
Ca2+ can signal to neurons, inducing
neuronal Ca2+ elevations (Nedergaard,
1994 ; Parpura et al., 1994 ; Hassinger et al., 1995 ; Pasti et al., 1997 ;
Bezzi et al., 1998 ), regulating neuronal excitability (Araque et al.,
1998a , 1999b ; Newman and Zahs, 1998 ), and modulating synaptic
transmission (Araque et al., 1998a ,b ; Kang et al., 1998 ). Therefore,
astrocytes and neurons may function as a network where bi-directional
communication takes place (Pasti et al., 1997 ; for review, see Araque
et al., 1999a ).
Glutamate released from astrocytes is the signal responsible for the
modulation of neuronal activity and synaptic transmission by astrocytes
in cultured hippocampal cells (Araque et al., 1998a ,b , 1999b ; Sanzgiri
et al., 1999 ), hippocampal slices (Pasti et al., 1997 ; Bezzi et
al., 1998 ; Kang et al., 1998 ), and intact retina (Newman and Zahs,
1998 ). Although astrocytes can release glutamate through the reverse
operation of glutamate transporters (Szatkowski et al., 1990 ) or by a
swelling-induced mechanism (Kimelberg et al., 1990 ), astrocyte-induced
modulation of neuronal activity is attributable to glutamate released
through a Ca2+-dependent process (Araque
et al., 1998a ,b ; Bezzi et al., 1998 ; Newman and Zahs, 1998 ). Although
prolonged incubation with tetanus toxin can reduce the release of
glutamate from astrocytes (Bezzi et al., 1998 ), the cellular mechanism
responsible for this Ca2+-dependent
release of glutamate from astrocytes is poorly understood.
It has been shown that core proteins of the SNARE complex,
synaptobrevin II and syntaxin, are expressed in astrocytes (Parpura et
al., 1995 ), raising the possibility that
Ca2+-dependent glutamate release is
mediated by a vesicular mechanism. To begin to test this possibility,
we now use pharmacological tools that interact with the function of two
vesicle-associated proteins, vacuolar-type
H+-ATPase (V-ATPase) and synaptobrevin,
that are essential in neurotransmitter release (Schiavo et al., 1992 ;
Liu and Edwards, 1997 ). We monitored the glutamate release from
astrocytes using well characterized glutamate-dependent
electrophysiological responses to stimulation of astrocytes, i.e., a
neuronal slow inward current (SIC) and/or an increase in the frequency
of miniature postsynaptic currents (mPSCs) (Araque et al., 1998a ,b ;
Kang et al., 1998 ). We demonstrate that the
Ca2+-dependent glutamate release from
astrocytes is not caused by the reverse operation of glutamate
transporters. However, bafilomycin A1, a V-ATPase
inhibitor that dissipates the electrochemical proton gradient necessary
for glutamate uptake into vesicles (Maycox et al., 1988 ), reduced the
astrocyte-induced neuronal responses without affecting astrocyte
Ca2+ waves. Furthermore, injection of
astrocytes with the light chain of the neurotoxin Botulinum B (BoNT/B),
which selectively cleaves the vesicle-associated SNARE protein
synaptobrevin (Schiavo et al., 1992 ), did not prevent
Ca2+ signaling in astrocytes but strongly
reduced the astrocyte-induced responses in neurons. We conclude that
Ca2+-dependent glutamate release from
astrocytes requires the presence of functional vesicle-associated proteins.
 |
MATERIALS AND METHODS |
Preparation. Primary cultures of mixed hippocampal
neurons and astrocytes from 1- to 3-d-old postnatal rats were prepared as described previously (Araque et al., 1998a ) and used after 6-25 d
in culture. At the time of use, astrocytes were confluent in these
cultures. In some experiments, cells were plated on coverslips coated
with 0.15% agarose and sprayed with poly-D-lysine (0.3 mg/ml) and collagen (0.4 mg/ml) using an atomizer, which produced microdrops where cells grew forming microislands of astrocytes and neurons.
Electrophysiology. Whole-cell patch-clamp recordings were
obtained from neurons with an Axopatch-1C amplifier and pClamp software (Axon Instruments, Foster City, CA). Currents were filtered at 1-2 kHz
and sampled above 1 kHz. External control solution contained (in
mM): 140 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES, 10 glucose, and 6 sucrose, pH
7.35. Because Araque et al. (1998a) demonstrated that the SIC is partly
mediated through NMDA glutamate receptors, in some experiments NMDA
receptor activation was optimized by omitting
Mg2+ and adding 10 µM
glycine to the solution. The patch pipette solution contained (in
mM): 140 K-gluconate, 10 EGTA, 4 Mg-ATP, 0.2 Tris-GTP, and
10 HEPES, pH 7.35. The membrane potential was held at 60 mV.
The morphological identification of neurons was confirmed
electrophysiologically by their ability to generate TTX-sensitive Na+-mediated action potentials and by the
presence of fast synaptic currents. Astrocytes were stimulated
mechanically using glass micropipettes filled with external saline
(Charles, 1994 ; Nedergaard, 1994 ; Araque et al., 1998a ). We have
previously shown that contact between a patch pipette and an astrocyte
causes the Ca2+-dependent release of
glutamate and a glutamate-dependent SIC in adjacent neurons (Araque et
al., 1998a ). This SIC is caused by the regulated release of glutamate
from astrocytes, because attenuation of the astrocyte
Ca2+ signal by either injection of the
Ca2+ chelator BAPTA or treatment with
thapsigargin prevents the appearance of the SIC in neurons (Araque et
al., 1998a ). In some experiments, astrocytes were stimulated by focal
application of norepinephrine (10 mM) delivered by pressure
ejection (0.5 sec, 10-20 psi) (Narishige IM-200, Narishige, Greenvale,
NY) from a micropipette, which was positioned using an Eppendorf
micromanipulator. Unless stated otherwise, the incidence of
astrocyte-induced responses was defined as the proportion of responses
relative to the total number of astrocytes stimulated in each
experiment; at least eight astrocytes were stimulated in each parallel
control and test condition, and data were obtained from at least three
different experiments (i.e., at least 24 astrocytes were stimulated in
each condition). Likewise, to determine the number of neurons eliciting
postsynaptic currents, at least 11 putative presynaptic neurons were
stimulated in each parallel control and test condition, and data were
obtained from at least three different experiments. Therefore, for
these variables, n values correspond to number of
preparations, whereas for the other variables, such as the amplitude of
the SIC, n represents the number of cells examined.
Statistical differences were established using the Student's
t test, unless stated otherwise. All experiments were
performed at room temperature (20-23°C). Data are expressed as
mean ± SEM.
Calcium measurements. The ability of stimuli to evoke a wave
of elevated Ca2+ in astrocytes was
monitored by fluorescence microscopy using the
Ca2+ indicators fluo-3 or fluo-4. Cultures
were incubated at 37°C for 15-30 min with the acetoxymethyl ester of
those indicators (10 µg/ml; Molecular Probes, Eugene, OR), and then
washed for 20-30 min. Coverslips containing either fluo-3- or
fluo-4-loaded cells were visualized using a silicon intensified target
camera (Hamamatsu Photonic System, Bridgewater, NJ) or IC-300
intensified CCD camera (Photon Technology International, Monmouth
Junction, NJ) attached to a Nikon 300 inverted microscope and a
NeDLC optical workstation (Prairie Technologies,
LLC, Waunakee, WI). Quantitative fluorescence measurements were made
using the NeDLC video software.
Microinjection into astrocytes. Individual astrocytes were
microinjected with fluoro-ruby, the light chain of the neurotoxin BoNT/B (List Biological Laboratories, Campbell, CA) and the
Ca2+ chelator BAPTA, separately or in
combination, as described elsewhere (Araque et al., 1998a ).
Microinjection pipettes (tip diameter of ~400 nm) were pulled from
Kwik-Fil borosilicate glass capillaries (World Precision Instruments,
Sarasota, FL) using a Sutter P-2000 micropipette puller (Sutter
Instrument Co., Novato, CA), and they were filled with 1 mM
fluoro-ruby, 83.3 µg/ml BoNT/B, and 0.1 M BAPTA. Because
fluoro-ruby contains a dextran moiety that prevents its passage through
gap junctions, the dye was retained within the injected cell, allowing
the identification of the injected cells. Pipette solutions were
pressure-injected into single astrocytes by a 1-15 sec pulse of 0.1-5
psi using an Eppendorf micromanipulator and a Narishige IM-200
microinjector. Based on quantification of the fluoro-ruby fluorescence
(Araque et al., 1998a ), the final intracellular concentrations were
estimated to be 333 ng/ml for BoNT/B and 0.4 mM for BAPTA.
After injections, cells were allowed to recover for 45-60 min before
electrophysiology, Ca2+ imaging
experiments, or immunocytochemistry was performed.
Immunocytochemistry. Cells were fixed with 4%
paraformaldehyde in PBS at room temperature for 30 min. Synaptobrevin
II was immunocytochemically detected using a monoclonal antibody (clone 69.1, 1:500; provided by Dr. R. Jahn, Max Planck Institute)
visualized by using an FITC-conjugated secondary antibody. After
washing, cells were mounted in n-propyl gallate glycerol and
examined using conventional epifluorescence microscopy and
laser-scanning confocal microscopy.
 |
RESULTS |
The astrocyte-induced SIC is not mediated by reverse operation of
glutamate transporters
To study the astrocyte-to-neuron signaling, we have used
mechanical stimulation to evoke Ca2+
elevations in astrocytes (Charles et al., 1991 ; Nedergaard, 1994 ; Araque et al., 1998a ,b ). This Ca2+
elevation is both necessary and sufficient to cause the release of
glutamate from astrocytes (Araque et al., 1998a ,b ), which in turn
causes CNQX- and AP5-sensitive SICs in adjacent neurons (Araque et al.,
1998a ,b ). This time course is a characteristic of the response, because
a similar time course has been observed when different stimuli have
been used, e.g., photorelease of Ca2+
after NP-EGTA injection (Araque et al., 1998b ) or astrocyte stimulation with PGE2 (Sanzgiri et al., 1999 ). Although
mechanical stimulation is not physiological, it does mimic the action
of endogenous ligands (Sanzgiri et al., 1999 ) and photorelease of
Ca2+ (Araque et al., 1998b ) in its ability
to stimulate Ca2+-dependent glutamate
release from astrocytes and affords the advantage that the stimulus can
be directly applied to astrocytes. Consequently, for
Ca2+ waves and astrocyte-neuron signaling
studies, mechanical stimuli have become the experimental stimulus of
choice (Araque et al., 1999a ).
Szatkowski et al. (1990) reported that glutamate can be released from
glia through the reverse operation of the glutamate transporters. We
investigated whether a similar mechanism is responsible for the
Ca2+-dependent glutamate-mediated
electrophysiological responses detected in neurons after
Ca2+ elevations in astrocytes. We analyzed
the effects of the inhibitors of the glutamate transporters
L-trans-pyrrolidine-2,4-dicarboxylate (t-PDC; 1 mM), -threo-hydroxyaspartate ( -HA; 0.3-1
mM), and dihydrokainate (DHK; 1 mM) on the astrocyte-induced responses in
adjacent neurons. The proportion of mechanically stimulated astrocytes
that evoked neuronal responses and the amplitude of the
astrocyte-induced SIC were unaffected by t-PDC, DHK, or -HA (Table
1). Because the glutamate transporters
also co-transport sodium (but not lithium) across the membrane, we
asked whether the replacement of the extracellular sodium by lithium
would increase the SIC amplitude by increasing the reverse operation of
the sodium-mediated glutamate carriers. We found that neither the
incidence nor the amplitude of the astrocyte-mediated SIC in neurons
was significantly affected by substitution of
Na+ with Li+
(Table 1). These results indicate that the glutamate transporters are
not required for Ca2+-dependent glutamate
release from astrocytes.
Bafilomycin A1 reduces the magnitude of synaptic
transmission and astrocyte-neuron signaling
Vesicular uptake of neurotransmitters requires a transmembrane
electrochemical proton gradient maintained by a V-ATPase that is
potently and selectively inhibited by bafilomycin
A1 (Bowman et al., 1988 ; Maycox et al., 1988 ;
Carlson et al., 1989 ; Hanada et al., 1990 ; Moriyama et al., 1990 ;
Roseth et al., 1995 ). Therefore, to investigate the cellular mechanisms
involved in the glutamate release from astrocytes we have used
bafilomycin A1 as a pharmacological tool that
prevents the uptake and storage of glutamate in vesicles.
We first investigated the effects of bafilomycin on synaptic
transmission, a well known vesicle-mediated exocytotic process. We
extracellularly stimulated up to three putative presynaptic neurons
(physically in contact with a process of a potential postsynaptic neuron) while recording from a postsynaptic neuron. Ten stimuli were
delivered at 1 Hz, and the presence of postsynaptic currents was
recorded. In control conditions, stimulation of most of the putative
presynaptic neurons (97.4 ± 2.6%; n = 25 cell
pairs in three preparations) evoked synaptic currents in the potential postsynaptic neuron (Fig.
1A), indicating that
most of the neurons in physical contact were synaptically connected and
their synaptic machinery was functional. In parallel cultures incubated
with 1-5 µM bafilomycin for 60-90 min, the
number of presynaptic neurons that elicited synaptic currents was
significantly reduced (from 97.4 ± 2.6% in control to 47.0 ± 13.6% in bafilomycin; n = 35 cell pairs in three
preparations; p < 0.05), without modifying the ability
of neurons to exhibit all-or-none action potentials (data not shown).
The mean amplitude of the evoked EPSCs was strongly reduced
after incubation with bafilomycin (Fig.
1B-D), and the relative number of
synaptic failures (i.e., absence of evoked EPSCs) was dramatically
increased by bafilomycin treatment (Fig. 1A,B,E). In support of
the possibility that bafilomycin acts on the secretory machinery, the
frequency of miniature EPSCs (mEPSCs) was significantly reduced by
bafilomycin. Those mEPSCs still detected in bafilomycin had an
amplitude similar to control mEPSCs (Fig. 1F,H), indicating a
presynaptic mechanism of action of bafilomycin. Because bafilomycin
decreases vesicle filling by reducing the vesicular electrochemical
gradient, one might expect to obtain a reduction of the mPSC amplitude,
a result that we did not observe. However, it is likely that smaller
mPSCs were beneath the detection level in our experiments, a result
that is in agreement with the observed reduction of the mPSC frequency.
Taken together, these results indicate that bafilomycin reduced the
probability of transmitter release, and they are in agreement with the
predicted effects of bafilomycin by preventing the uptake and storage
of neurotransmitter into synaptic vesicles.

View larger version (35K):
[in this window]
[in a new window]
|
Figure 1.
Bafilomycin A1 reduced the probability
of synaptic transmitter release. A, B,
Representative traces of evoked EPSCs in control cultures and after
incubation with bafilomycin. In many cases, EPSCs were absent in
bafilomycin-treated cultures. When present, the amplitude of EPSCs in
bafilomycin was smaller than in control, and the number of synaptic
failures was increased by bafilomycin. C, Averaged
(n = 10) EPSCs in control and bafilomycin. Shown is
the same pair of pre-postsynaptic neurons as in B. D,
Mean evoked EPSC amplitude in control and bafilomycin-treated cultures
(n = 25 and 35 presynaptic neurons, respectively).
E, Mean percentage of synaptic failures observed during
trials of 10 stimuli delivered at 1 Hz in control and after incubation
with bafilomycin (n = 25 and 35 presynaptic
neurons, respectively). F, mEPSCs in control and after
incubation with bafilomycin. G, Mean frequency of mEPSCs
measured during 1-4 min in control and in bafilomycin-treated cells
(n = 9). H, Average cumulative
probability plots of the mEPSC amplitude in control
(n = 9) and after incubation with bafilomycin
(n = 8). Cumulative probability plots were
calculated in 1 pA bins and were not significantly different between
control and bafilomycin-treated cells (Kolmogorov-Smirnov test).
Holding potential was 60 mV. Significant differences with respect to
control were established by the Student's t test at
p < 0.02 (**) and p < 0.001 (***).
|
|
Because incubation with bafilomycin was effective in reducing the
amount of neurotransmitter released from synaptic terminals, we asked
whether it also reduced glutamate release from astrocytes by
determining the effects of bafilomycin on the glutamate-dependent neuronal responses elicited by mechanical stimulation of astrocytes. In
control conditions, neuronal responses were elicited by 63.4 ± 2.8% of the stimulated astrocytes (n = 46 stimulated
astrocytes in three preparations), whereas their incidence was
significantly reduced (p < 0.001) after
bafilomycin treatment (32.5 ± 2.8%; n = 48 stimulated astrocytes in three preparations) (Fig.
2B). Just as in our
synaptic recordings, the amplitude of the astrocyte-induced SIC was
also significantly reduced by bafilomycin (Fig.
2A,C). One concern with the
interpretation of these results is whether the SIC reduction is
secondary to the effects of bafilomycin on synaptic transmission. This
is unlikely to be the case because our previous studies (Araque et al.,
1998a ) have shown that incubation of cultures in tetanus toxin
holoprotein, which blocked synaptic transmission, did not impact the
SIC that is caused by glutamate release from astrocytes. Thus, it is
likely that the reduction in incidence and amplitude of the SIC after
bafilomycin treatment is attributable to direct effects of the V-ATPase
inhibitor on astrocytes.

View larger version (41K):
[in this window]
[in a new window]
|
Figure 2.
Bafilomycin reduced astrocyte-evoked neuronal
responses but did not prevent Ca2+ waves in
astrocytes. A, Representative whole-cell current
neuronal responses to astrocyte stimulation in control
(left) and after incubation with bafilomycin
(right). Mechanical stimulation of astrocytes is
indicated by asterisk. Fast, high-amplitude synaptic
currents have been truncated. B, Proportion of
mechanically stimulated astrocytes that evoked glutamate-dependent
responses in adjacent neurons in control and bafilomycin-treated
cultures (n = 3 different cultures).
C, Current amplitude recorded in neurons after
mechanical stimulation of adjacent astrocytes in control and
bafilomycin-treated cells (n = 37 and 45 stimulated
astrocytes, respectively). Significant differences with respect to
control were established by the Student's t test at
p < 0.01 (**) and p < 0.001 (***). D, E, Mechanically induced
Ca2+ waves recorded in cultures loaded with the
Ca2+ indicator fluo-3 in control conditions and
after incubation with bafilomycin. Left to right
panels show pseudocolor images representing intensity of fluo-3
emission, taken before, during, and after mechanical stimulation, at
the times indicated. Zero time corresponds to the time of astrocyte
stimulation. Mechanical stimulation increased the intracellular
Ca2+ in the injected cell as well as in neighboring
nonstimulated astrocytes.
|
|
Although these data are consistent with the possibility that the
glutamate released from astrocytes is stored in an acidic compartment
that is sensitive to bafilomycin, it is important to confirm the
specificity of bafilomycin action. Although bafilomycin is reported to
have a higher affinity for the V-ATPase than the Ca2+-ATPase, it is necessary to confirm
that bafilomycin does not reduce glutamate release as a result of
inhibiting the Ca2+-ATPase and thus the
Ca2+ signal that is necessary to stimulate
glutamate release. Mechanically induced
Ca2+ waves in astrocytes were elicited by
12 of 13 stimulated astrocytes in control conditions (Fig.
2D), and by eight of eight astrocytes after
incubation with bafilomycin (Fig. 2E), indicating
that the effects of bafilomycin on the SIC were not caused by the
impairment of the stimulus-induced Ca2+
elevation in astrocytes. Taken together, these results indicate that
the release of glutamate from astrocytes requires the presence of the
functional V-ATPase, a vesicle-associated protein necessary for the
uptake and storage of neurotransmitters in vesicles.
The vesicle-associated protein synaptobrevin is required for
glutamate release from astrocytes
Synaptobrevin is a vesicle-associated SNARE protein involved in
exocytosis from synaptic terminals that has been demonstrated to be
expressed by both neurons (Schiavo et al., 1992 ;
Fernández-Chacón and Südhof, 1999 ) and astrocytes
(Parpura et al., 1995 ; Araque et al., 1998a ; Maienschein et al., 1999 ).
Synaptobrevin can be selectively cleaved by Botulinum toxin B (Schiavo
et al., 1992 ), a clostridial toxin constituted by a heavy and a light
chain with receptor binding and proteolytic properties, respectively
(Ahnert-Hilger and Bigalke, 1995 ). Because high concentrations of
clostridial toxin receptors are present on nerve cells but are
practically absent on glial cells (Ahnert-Hilger and Bigalke, 1995 ),
the holotoxin acts selectively on neurons (Araque et al., 1998a ).
Therefore, to investigate the involvement of synaptobrevin on glutamate
release from astrocytes, we bypassed the steps required for the
Botulinum B holotoxin to become intracellularly active (i.e., binding,
internalization, and reduction) by directly microinjecting the light
chain of the neurotoxin BoNT/B into single astrocytes. In addition, we
concurrently injected the fluorescent indicator fluoro-ruby to label
the injected cell.
To confirm that synaptobrevin was cleaved after injection with BoNT/B,
we performed immunocytochemistry using an antibody against
synaptobrevin II that was visualized using an FITC-conjugated secondary
antibody (Fig.
3A,B).
Although the anti-synaptobrevin fluorescent signal was similar in
control uninjected cells and in cells injected with fluoro-ruby alone
(n = 4) (Fig. 3C), it was markedly reduced
in cells injected with BoNT/B (n = 6) (Fig. 3D).

View larger version (56K):
[in this window]
[in a new window]
|
Figure 3.
Microinjection of the light chain of the Botulinum
toxin B (BoNT/B) into astrocytes reduces synaptobrevin
immunofluorescence. An individual astrocyte in a microisland was
microinjected with fluoro-ruby (A) together with
the light chain of BoNT/B. Subsequent immunostaining of the preparation
with anti-synaptobrevin II showed a reduced immunoreactivity in the
microinjected cell (B). Images in
A and B were constructed from a stack of
16 successive images (2 µm deep) obtained with laser scanning
confocal microscopy. Boxes show regions used to compute
average linescan fluorescent intensities (20 lines wide) that are
presented in D. In C and
D, the normalized intensities of fluoro-ruby and
anti-synaptobrevin immunoreactivity are shown as average line scans. In
BoNT/B-injected astrocytes (D), the intensity of
the anti-synaptobrevin immunoreactivity (green
line) is reduced in the region that corresponds to the injected
cell (red line), whereas in astrocytes injected
with fluoro-ruby alone (C, original micrographs are not
shown), it remains constant in comparison to neighboring uninjected
cells.
|
|
We determined whether the injection of BoNT/B affected
Ca2+ signaling in astrocytes by loading
cells with the Ca2+ indicator fluo-4 (Fig.
4). Mechanical stimulation of uninjected astrocytes (18 of 21) or astrocytes injected with fluoro-ruby alone
(five of six) increased the intracellular
Ca2+ in the directly stimulated cell and
evoked Ca2+ waves in neighboring
astrocytes. These results confirm that neither the injection procedure
per se nor the injection of fluoro-ruby affects the ability of
astrocytes to respond to direct stimulation or to evoke
Ca2+ waves (Araque et al., 1998a ,b ).
Mechanically induced Ca2+ wave generation
was also unaffected by injection of BoNT/B into the stimulated
astrocytes (10 of 11). However, the Ca2+
elevation in astrocytes and the generation of
Ca2+ waves were practically prevented when
BAPTA was coinjected (only one of eight injected astrocytes evoked
Ca2+ waves), confirming the suitability of
the injection procedure.

View larger version (42K):
[in this window]
[in a new window]
|
Figure 4.
Astrocyte Ca2+ wave
propagation was unaffected by injection of BoNT/B. A,
Mechanically induced Ca2+ wave recorded in
astrocytes loaded with the Ca2+ indicator fluo-4 in
control conditions. Panels show images in pseudocolor
mode representing intensity of fluo-4 emission, taken before, during,
and after mechanical stimulation, at the times indicated. Zero time
corresponds to the time of astrocyte stimulation. Mechanical
stimulation increases intracellular Ca2+ in the
injected cell as well as in neighboring non-stimulated astrocytes.
B, Stimulation of a single astrocyte microinjected
with fluoro-ruby and BoNT/B (left panel)
increases the intracellular Ca2+ in the injected
cell as well as in neighboring unstimulated astrocytes. Right
panels show pseudocolor images representing intensity of fluo-4
emission at the times indicated in A. Zero time
corresponds to the time of astrocyte stimulation. C, As
in B but with a single astrocyte microinjected with
fluoro-ruby, BoNT/B, and BAPTA (left panel).
Mechanical stimulation of the injected cell did not change the
fluorescent emission of fluo-4 in either the stimulated or neighboring
astrocytes (right panels).
|
|
To further confirm that the Ca2+ signal
was preserved in BoNT/B-injected astrocytes, we analyzed the
involvement of the injected astrocytes in
Ca2+ waves generated by adjacent
astrocytes and the ability of those astrocytes to generate
ligand-evoked Ca2+ waves. We found that
eight of nine BoNT/B-injected astrocytes participated in
Ca2+ waves initiated by adjacent
astrocytes that were stimulated either mechanically or by pressure
ejection of norepinephrine (NE). Furthermore, the susceptibility of
astrocytes to directly respond to NE was unmodified by injection of
BoNT/B. Indeed, Ca2+ waves were similarly
generated by focal application of NE to uninjected or BoNT/B-injected
astrocytes (six of six, and five of five astrocytes, respectively).
Taken together, these results indicate that both the signal
transduction and the related intracellular second messenger system
underlying the generation and propagation of
Ca2+ waves were still functional after
microinjection of BoNT/B, again confirming the healthy condition of the
injected astrocytes.
After determining that microinjected BoNT/B cleaves synaptobrevin
without affecting the overall physiology of astrocytes, we asked
whether it prevents glutamate release from astrocytes by monitoring the
SIC in neurons cultured on top of astrocytes. BoNT/B is unlikely to
pass through the gap junctions that interconnect astrocytes. Therefore,
to ensure that all astrocytes which make contact with neurons contained
BoNT/B and fluoro-ruby, we used microisland cultures containing a
maximum of four astrocytes and microinjected BoNT/B into each cell
(Fig. 5A). Mechanical
stimulation of uninjected astrocytes reliably induced a SIC in adjacent
neurons (8 of 11 stimulated astrocytes; mean current amplitude:
96.8 ± 26.6 pA). Similarly, 8 of 13 astrocytes that had been
injected with fluoro-ruby alone evoked neuronal SIC after astrocyte
stimulation (mean current amplitude: 69.2 ± 22.4 pA; which is not
significantly different from uninjected astrocytes). However, only 1 of
16 astrocytes injected with fluoro-ruby and BoNT/B induced a SIC in
adjacent neurons (mean current amplitude: 5.6 ± 5.6 pA; which is
significantly different from fluoro-ruby-injected astrocytes;
p < 0.01) (Fig. 5B-D). These
results indicate that microinjection into astrocytes of BoNT/B, which
selectively cleaves the SNARE protein synaptobrevin, prevented the
stimulus-induced Ca2+-dependent glutamate
release from astrocytes that is detected in associated neurons as a
SIC.

View larger version (53K):
[in this window]
[in a new window]
|
Figure 5.
BoNT/B prevents glutamate-mediated SIC in adjacent
neurons. A, Left panel, Phase-contrast
image of a microisland containing two astrocytes and two neurons (somas
indicated by arrows). Right panel,
Epifluorescence image of the same microisland after the microinjection
of both astrocytes with fluoro-ruby. B, Representative
whole-cell currents recorded from neurons in microislands in which the
astrocytes were microinjected with either fluoro-ruby
(left) or fluoro-ruby and BoNT/B (right).
Although mechanically stimulated astrocytes injected with fluoro-ruby
alone reliably evoked SIC in adjacent neurons, those injected with
BoNT/B failed to evoke SIC. Mechanical stimulation of the astrocyte is
indicated by the asterisk. Note the noise increase
during the SIC, which is probably caused by the activation of NMDA
receptors (Araque et al., 1998a ). C, Proportion of
mechanically stimulated astrocytes that evoked glutamate-dependent SIC
in adjacent neurons. D, Current amplitude recorded in
neurons after mechanical stimulation of adjacent astrocytes.
Significant differences were established by the Student's
t test at p < 0.01 (**).
|
|
 |
DISCUSSION |
Our present results suggest that vesicle-associated mechanisms
underlie the Ca2+-dependent glutamate
release from astrocytes that is involved in the astrocyte-to-neuron
signaling. Indeed, we have found that the
Ca2+-dependent, glutamate-mediated
neuronal electrophysiological responses elicited by mechanical
stimulation of astrocytes were not mediated by the reverse operation of
glutamate transporters, which is in agreement with previous findings
using Ca2+ imaging techniques and
enzymatic assays as well as different stimuli (e.g., bradykinin,
glutamate receptor agonists, photorelease of
Ca2+) (Parpura et al., 1994 ; Araque et
al., 1998b ; Bezzi et al., 1998 ).
By disrupting the function of two vesicle-associated proteins, V-ATPase
and synaptobrevin, that are known to be essential in neurotransmitter
release from synaptic terminals (Schiavo et al., 1992 ; Simpson et al.,
1994 ; Cousin et al., 1995 ; Pocock et al., 1995 ; Liu and Edwards, 1997 ;
Stevens and Forgac, 1997 ; Deitcher et al., 1998 ; Nonet et al., 1998 ;
Fernández-Chacón and Südhof, 1999 ), we examined the
participation of these vesicle-associated proteins in glutamate release
from astrocytes.
We have found that bafilomycin A1, a V-ATPase
inhibitor that dissipates the electrochemical proton gradient necessary
for glutamate uptake in vesicles (Bowman et al., 1988 ; Maycox et al., 1988 ; Carlson et al., 1989 ; Moriyama et al., 1990 ), reduced the ability
of astrocyte to release glutamate. Interestingly, although astrocyte
Ca2+ waves require functional internal
Ca2+ stores that can be depleted after
inhibition of the Ca2+-ATPase by
thapsigargin (Charles et al., 1993 ; Newman and Zahs, 1997 ; Araque et
al., 1998a ,b ), Ca2+ waves in astrocytes
were unaffected by the V-ATPase inhibitor, confirming that bafilomycin
did not affect other ATPases but selectively inhibited the V-ATPase
(Bowman et al., 1988 ). These results indicate that
Ca2+-dependent glutamate release from
astrocytes requires the functional presence of the vesicle-associated
protein V-ATPase, suggesting that the glutamate released by stimulation
of astrocytes is stored in a vesicular compartment.
We have also demonstrated that glutamate release from astrocytes was
strongly reduced after microinjection of astrocytes with the light
chain of the neurotoxin Botulinum B, which cleaved the vesicle-associated SNARE protein synaptobrevin. Our data are in agreement with previous studies showing that chronic treatment with
tetanus toxin (>12 hr) reduced the amount of glutamate released from
astrocytes (Jeftinija et al., 1997 ; Bezzi et al., 1998 ). However,
because of the prolonged incubation times used in these previous
studies, the physiological integrity of the astrocytes was uncertain.
In this study we microinjected the active chain of Botulinum toxin to
perform experiments on the time frame of ~1 hr after microinjection.
What is more, Ca2+ imaging studies support
the specificity of toxin action and demonstrate the physiological
integrity of astrocytes. Because our previous studies have shown that
astrocytes express synaptobrevin II and syntaxin (Parpura et al.,
1995 ), and because BoNT/B blocks the Ca2+-dependent SIC, our studies indicate
that the Ca2+-dependent release of
glutamate from astrocytes is a SNARE protein-dependent process.
Although these results strongly implicate a vesicular mode of glutamate
release, further studies are required, however, that must include an
ultrastructural analysis before it is possible to conclude that this
release pathway is mediated by exocytosis.
ATP released from astrocytes acts as a diffusible extracellular
messenger that is critical for the propagation of
Ca2+ waves between cultured astrocytes
(Cotrina et al., 1998 ; Guthrie et al., 1999 ). Although we did not study
ATP release per se, the fact that Ca2+
waves appeared unaffected by either BoNT/B injection or by bafilomycin treatment suggests that ATP is still released from astrocytes. Consequently, it is likely that ATP is released through a distinct mechanism from the glutamate release pathway.
The combined conclusions based on bafilomycin and Botulinum toxin
studies strongly implicate a vesicular compartment as mediating the
Ca2+-dependent release of glutamate from
astrocytes. Furthermore, because this
Ca2+-dependent glutamate signaling pathway
is present in acutely isolated preparations of brain slice (Bezzi et
al., 1998 ), it is not likely to be a peculiarity simply associated with
astrocytes in cell culture. Assuming that this property is present in
brain tissue, what structural form does it take? Characteristically, we
think of vesicle-mediated transmitter release as being associated with a cloud of vesicles as is often found in nerve terminals. However, the
processes of astrocytes that enwrap nerve terminals do not contain an
abundance of these structures. Thus, further evidence is needed before
it could be concluded that vesicles mediate glutamate release from
astrocytes. However, it is likely that few vesicles need be present to
mediate such release. At the developing neuromuscular junction, for
example, significant quantal release of acetylcholine, presumably
released from vesicles, can be detected at times when clearly defined
ultrastructural correlates of the synapse are lacking (Buchanan et al.,
1989 ).
In conclusion, our data support a requirement for SNARE proteins and a
vesicular electrochemical proton gradient for the release of glutamate
from astrocytes, raising the hypothesis that vesicle exocytosis
mediates this transmitter release.
 |
FOOTNOTES |
Received Sept. 13, 1999; revised Oct. 19, 1999; accepted Oct. 28, 1999.
This work was supported by grants from National Institutes of Health
(NS24233 and NS37585) and from the Iowa State University Biotechnology
Council to P.G.H., and by a long-term postdoctoral fellowship from the
Human Frontier Science Program to A.A. We thank Drs. W. Buño and
J. Lerma for their comments on this manuscript.
Correspondence should be addressed to Dr. Araque at his present
address: Instituto Cajal, Consejo Superior de Investigaciones Cientificas, Doctor Arce 37, Madrid 28002, Spain. E-mail:
araque{at}cajal.csic.es.
 |
REFERENCES |
-
Ahnert-Hilger G,
Bigalke H
(1995)
Molecular aspects of tetanus and botulinum neurotoxin poisoning.
Prog Neurobiol
46:83-96[Web of Science][Medline].
-
Araque A,
Parpura V,
Sanzgiri RP,
Haydon PG
(1998a)
Glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons.
Eur J Neurosci
10:2129-2142[Web of Science][Medline].
-
Araque A,
Sanzgiri RP,
Parpura V,
Haydon PG
(1998b)
Calcium elevation in astrocytes causes an NMDA receptor-dependent increase in the frequency of miniature synaptic currents in cultured hippocampal neurons.
J Neurosci
18:6822-6829[Abstract/Free Full Text].
-
Araque A,
Parpura V,
Sanzgiri RP,
Haydon PG
(1999a)
Tripartite synapses: glia, the unacknowledged partner.
Trends Neurosci
22:208-215[Web of Science][Medline].
-
Araque A,
Sanzgiri RP,
Parpura V,
Haydon PG
(1999b)
Astrocyte-induced modulation of synaptic transmission.
Can J Physiol Pharmacol
77:699-706[Web of Science][Medline].
-
Bezzi P,
Carmignoto G,
Pasti L,
Vesce S,
Rossi D,
Lodi Rizzini B,
Pozzan T,
Volterra A
(1998)
Prostaglandins stimulate calcium-dependent glutamate release in astrocytes.
Nature
391:281-285[Medline].
-
Bowman EJ,
Siebers A,
Altendorf K
(1988)
Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells and plant cells.
Proc Natl Acad Sci USA
85:7972-7976[Abstract/Free Full Text].
-
Buchanan J,
Sun YA,
Poo MM
(1989)
Studies of nerve-muscle interactions in Xenopus cell culture: fine structure of early functional contacts.
J Neurosci
9:1540-1554[Abstract].
-
Carlson MD,
Kish PE,
Ueda T
(1989)
Characterization of the solubilized and reconstituted ATP-dependent vesicular glutamate uptake system.
J Biol Chem
264:7369-7376[Abstract/Free Full Text].
-
Charles AC
(1994)
Glia-neuron intercellular calcium signaling.
Dev Neurosci
16:196-206[Web of Science][Medline].
-
Charles AC,
Merrill JE,
Dirksen ER,
Sanderson MJ
(1991)
Intercellular signaling in glial cells: calcium waves and oscillations in response to mechanical stimulation and glutamate.
Neuron
6:983-992[Web of Science][Medline].
-
Charles AC,
Dirksen ER,
Merrill JE,
Sanderson MJ
(1993)
Mechanisms of intercellular calcium signaling in glial cells studied with dantrolene and thapsigargin.
Glia
7:134-145[Web of Science][Medline].
-
Cornell-Bell AH,
Finkbeiner SM,
Cooper MS,
Smith SJ
(1990)
Glutamate induces calcium waves in cultured astrocytes: long-range glial signalling.
Science
247:470-473[Abstract/Free Full Text].
-
Cotrina ML,
Lin JH,
Alves-Rodrigues A,
Liu S,
Li J,
Azmi-Ghadimi H,
Kang J,
Naus CC,
Nedergaard M
(1998)
Connexins regulate calcium signaling by controlling ATP release.
Proc Natl Acad Sci USA
95:15735-15740[Abstract/Free Full Text].
-
Cousin MA,
Nicholls DG,
Pocock JM
(1995)
Modulation of ion gradients and glutamate release in cultured cerebellar granule cells by ouabain.
J Neurochem
64:2097-2104[Web of Science][Medline].
-
Dani JW,
Chernjavsky A,
Smith SJ
(1992)
Neuronal activity triggers calcium waves in hippocampal astrocyte networks.
Neuron
8:429-440[Web of Science][Medline].
-
Deitcher DL,
Ueda A,
Stewart BA,
Burgess RW,
Kidokoro Y,
Schwarz TL
(1998)
Distinct requirements for evoked and spontaneous release of neurotransmitter are revealed by mutations in the Drosophila gene neuronal-synaptobrevin.
J Neurosci
18:2028-2039[Abstract/Free Full Text].
-
Fernández-Chacón R,
Südhof TC
(1999)
Genetics of synaptic vesicle function: toward the complete functional anatomy of an organelle.
Annu Rev Physiol
61:753-776[Web of Science][Medline].
-
Guthrie PB,
Knappenberger J,
Segal M,
Bennet MVL,
Charles AC,
Kater SB
(1999)
ATP released from astrocytes mediates glial calcium waves.
J Neurosci
19:520-528[Abstract/Free Full Text].
-
Hanada H,
Moriyama Y,
Maeda M,
Futai M
(1990)
Kinetic studies of chromaffin granule H+-ATPase and effects of bafilomycin A1.
Biochem Biophys Res Commun
170:873-878[Web of Science][Medline].
-
Hassinger TD,
Atkinson PB,
Strecker GJ,
Whalen LR,
Dudek FE,
Koseel AH,
Kater SB
(1995)
Evidence for glutamate-mediated activation of hippocampal neurons by glial calcium waves.
J Neurobiol
28:159-170[Web of Science][Medline].
-
Jeftinija SD,
Jeftinija KV,
Stefanovic G
(1997)
Cultured astrocytes express proteins involved in vesicular glutamate release.
Brain Res
750:41-47[Web of Science][Medline].
-
Kang J,
Jiang L,
Goldman SA,
Nedergaard M
(1998)
Astrocyte-mediated potentiation of inhibitory synaptic transmission.
Nat Neurosci
1:683-692[Web of Science][Medline].
-
Kimelberg HK,
Goderie SK,
Higman S,
Pang S,
Waniewski RA
(1990)
Swelling-induced release of glutamate, aspartate, and taurine from astrocytes cultures.
J Neurosci
10:1583-1591[Abstract].
-
Liu Y,
Edwards RH
(1997)
The role of vesicular transport proteins in synaptic transmission and neural degeneration.
Annu Rev Neurosci
20:125-156[Web of Science][Medline].
-
Maienschein V,
Marxen M,
Volknandt W,
Zimmermann H
(1999)
A plethora of presynaptic proteins associated with ATP-storing organelles in cultured astrocytes.
Glia
26:233-244[Web of Science][Medline].
-
Maycox PR,
Deckwerth T,
Hell JW,
Jahn R
(1988)
Glutamate uptake by brain synaptic vesicles. Energy dependence of transport and functional reconstitution in proteoliposomes.
J Biol Chem
263:15423-15428[Abstract/Free Full Text].
-
Moriyama Y,
Maeda M,
Futai M
(1990)
Energy coupling of L-glutamate transport and vacuolar H+-ATPase in brain synaptic vesicles.
J Biochem
108:689-693[Abstract/Free Full Text].
-
Nedergaard M
(1994)
Direct signaling from astrocytes to neurons in cultures of mammalian brain cells.
Science
263:1768-1771[Abstract/Free Full Text].
-
Newman EA,
Zahs KR
(1997)
Calcium waves in retinal glial cells.
Science
275:844-847[Abstract/Free Full Text].
-
Newman EA,
Zahs KR
(1998)
Modulation of neuronal activity by glial cells in the retina.
J Neurosci
18:4022-4028[Abstract/Free Full Text].
-
Nonet ML,
Saifee O,
Zhao H,
Rand JB,
Wei L
(1998)
Synaptic transmission deficits in Caenorhabditis elegans synaptobrevin mutants.
J Neurosci
18:70-80[Abstract/Free Full Text].
-
Parpura V,
Basarsky TA,
Liu F,
Jeftinija K,
Jeftinija S,
Haydon PG
(1994)
Glutamate-mediated astrocyte-neuron signalling.
Nature
369:744-747[Medline].
-
Parpura V,
Fang Y,
Basarsky TA,
Jahn R,
Haydon PG
(1995)
Expression of synaptobrevin II, cellubrevin and syntaxin but not SNAP-25 in cultured astrocytes.
FEBS Lett
377:489-492[Web of Science][Medline].
-
Pasti L,
Volterra A,
Pozzan T,
Carmignoto G
(1997)
Intracellular calcium oscillations in astrocytes: a highly plastic, bidirectional form of communication between neurons and astrocytes in situ.
J Neurosci
17:7817-7830[Abstract/Free Full Text].
-
Pocock JM,
Cousin MA,
Parkin J,
Nicholls DG
(1995)
Glutamate exocytosis from cerebellar granule cells: the mechanism of a transition to an L-type Ca2+ channel coupling.
Neuroscience
67:595-607[Web of Science][Medline].
-
Porter JT,
McCarthy KD
(1996)
Hippocampal astrocytes in situ respond to glutamate released from synaptic terminals.
J Neurosci
16:5073-5081[Abstract/Free Full Text].
-
Roseth S,
Fykse EM,
Fonnum F
(1995)
Uptake of L-glutamate into rat brain synaptic vesicles: effect of inhibitors that bind specifically to the glutamate transporter.
J Neurochem
65:96-103[Web of Science][Medline].
-
Sanzgiri RP,
Araque A,
Haydon PG
(1999)
Prostaglandin E2 stimulates glutamate receptor-dependent astrocyte neuromodulation in cultured hippocampal cells.
J Neurobiol
41:221-229[Web of Science][Medline].
-
Schiavo G,
Benfenati F,
Poulain B,
Rossetto O,
Polverino de Laureto P,
DasGupta BR,
Montecucco C
(1992)
Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.
Nature
359:832-835[Medline].
-
Simpson LL,
Coffield JA,
Bakry N
(1994)
Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
J Pharmacol Exp Ther
269:256-262[Abstract/Free Full Text].
-
Stevens TH,
Forgac M
(1997)
Structure, function and regulation of the vacuolar (H+)-ATPase.
Annu Rev Cell Dev Biol
13:779-808[Web of Science][Medline].
-
Szatkowski M,
Barbour B,
Attwell D
(1990)
Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake.
Nature
348:443-447[Medline].
Copyright © 2000 Society for Neuroscience 0270-6474/00/202666-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. Jiang and G. Chen
Ca2+ Regulation of Dynamin-Independent Endocytosis in Cortical Astrocytes
J. Neurosci.,
June 24, 2009;
29(25):
8063 - 8074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-T. Liu, T. Akita, T. Shimizu, R. Z. Sabirov, and Y. Okada
Bradykinin-induced astrocyte\#8211;neuron signalling: glutamate release is mediated by ROS-activated volume-sensitive outwardly rectifying anion channels
J. Physiol.,
May 15, 2009;
587(10):
2197 - 2209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Pawson, L. T. Prestia, G. K. Mahoney, B. Guclu, P. J. Cox, and A. K. Pack
GABAergic/Glutamatergic-Glial/Neuronal Interaction Contributes to Rapid Adaptation in Pacinian Corpuscles
J. Neurosci.,
March 4, 2009;
29(9):
2695 - 2705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sakatani, A. Seto-Ohshima, Y. Shinohara, Y. Yamamoto, H. Yamamoto, S. Itohara, and H. Hirase
Neural-Activity-Dependent Release of S100B from Astrocytes Enhances Kainate-Induced Gamma Oscillations In Vivo
J. Neurosci.,
October 22, 2008;
28(43):
10928 - 10936.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Theodosis, D. A. Poulain, and S. H. R. Oliet
Activity-Dependent Structural and Functional Plasticity of Astrocyte-Neuron Interactions
Physiol Rev,
July 1, 2008;
88(3):
983 - 1008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Shigetomi, D. N. Bowser, M. V. Sofroniew, and B. S. Khakh
Two Forms of Astrocyte Calcium Excitability Have Distinct Effects on NMDA Receptor-Mediated Slow Inward Currents in Pyramidal Neurons
J. Neurosci.,
June 25, 2008;
28(26):
6659 - 6663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Schummers, H. Yu, and M. Sur
Tuned Responses of Astrocytes and Their Influence on Hemodynamic Signals in the Visual Cortex
Science,
June 20, 2008;
320(5883):
1638 - 1643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Perea and A. Araque
Astrocytes Potentiate Transmitter Release at Single Hippocampal Synapses
Science,
August 24, 2007;
317(5841):
1083 - 1086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xu, H. Peng, N. Kang, Z. Zhao, J. H-C. Lin, P. K. Stanton, and J. Kang
Glutamate-induced Exocytosis of Glutamate from Astrocytes
J. Biol. Chem.,
August 17, 2007;
282(33):
24185 - 24197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Griffioen, C. Gorini, H. Jameson, and D. Mendelowitz
Purinergic P2X Receptors Mediate Excitatory Transmission to Cardiac Vagal Neurons in the Nucleus Ambiguus After Hypoxia
Hypertension,
July 1, 2007;
50(1):
75 - 81.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Lee, G. Mannaioni, H. Yuan, D. H. Woo, M. B. Gingrich, and S. F. Traynelis
Astrocytic control of synaptic NMDA receptors
J. Physiol.,
June 15, 2007;
581(3):
1057 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Bowser and B. S. Khakh
Two forms of single-vesicle astrocyte exocytosis imaged with total internal reflection fluorescence microscopy
PNAS,
March 6, 2007;
104(10):
4212 - 4217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wirkner, A. Gunther, M. Weber, S. J. Guzman, T. Krause, J. Fuchs, L. Koles, W. Norenberg, and P. Illes
Modulation of NMDA Receptor Current in Layer V Pyramidal Neurons of the Rat Prefrontal Cortex by P2Y Receptor Activation
Cereb Cortex,
March 1, 2007;
17(3):
621 - 631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Sweger, K. B. Casper, K. Scearce-Levie, B. R. Conklin, and K. D. McCarthy
Development of Hydrocephalus in Mice Expressing the Gi-Coupled GPCR Ro1 RASSL Receptor in Astrocytes
J. Neurosci.,
February 28, 2007;
27(9):
2309 - 2317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Domercq, L. Brambilla, E. Pilati, J. Marchaland, A. Volterra, and P. Bezzi
P2Y1 Receptor-evoked Glutamate Exocytosis from Astrocytes: CONTROL BY TUMOR NECROSIS FACTOR-{alpha} AND PROSTAGLANDINS
J. Biol. Chem.,
October 13, 2006;
281(41):
30684 - 30696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-K. Chen, Y.-F. Xiong, and Z. Zhou
"Kiss-and-Run" Exocytosis in Astrocytes
Neuroscientist,
October 1, 2006;
12(5):
375 - 378.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Haydon and G. Carmignoto
Astrocyte control of synaptic transmission and neurovascular coupling.
Physiol Rev,
July 1, 2006;
86(3):
1009 - 1031.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Seigneur, D. Kroeger, D. A. Nita, and F. Amzica
Cholinergic Action on Cortical Glial Cells In Vivo
Cereb Cortex,
May 1, 2006;
16(5):
655 - 668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Rastaldi, S. Armelloni, S. Berra, N. Calvaresi, A. Corbelli, L. A. Giardino, M. Li, G. Q. Wang, A. Fornasieri, A. Villa, et al.
Glomerular podocytes contain neuron-like functional synaptic vesicles
FASEB J,
May 1, 2006;
20(7):
976 - 978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Crippa, U. Schenk, M. Francolini, P. Rosa, C. Verderio, M. Zonta, T. Pozzan, M. Matteoli, and G. Carmignoto
Synaptobrevin2-expressing vesicles in rat astrocytes: insights into molecular characterization, dynamics and exocytosis
J. Physiol.,
February 1, 2006;
570(3):
567 - 582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kang, J. Xu, Q. Xu, M. Nedergaard, and J. Kang
Astrocytic Glutamate Release-Induced Transient Depolarization and Epileptiform Discharges in Hippocampal CA1 Pyramidal Neurons
J Neurophysiol,
December 1, 2005;
94(6):
4121 - 4130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Pascual, K. B. Casper, C. Kubera, J. Zhang, R. Revilla-Sanchez, J.-Y. Sul, H. Takano, S. J. Moss, K. McCarthy, and P. G. Haydon
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Science,
October 7, 2005;
310(5745):
113 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Rose, W. Kresse, and H. Kettenmann
Acute Insult of Ammonia Leads to Calcium-dependent Glutamate Release from Cultured Astrocytes, an Effect of pH
J. Biol. Chem.,
June 3, 2005;
280(22):
20937 - 20944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Mothet, L. Pollegioni, G. Ouanounou, M. Martineau, P. Fossier, and G. Baux
Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter D-serine
PNAS,
April 12, 2005;
102(15):
5606 - 5611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Perea and A. Araque
Properties of Synaptically Evoked Astrocyte Calcium Signal Reveal Synaptic Information Processing by Astrocytes
J. Neurosci.,
March 2, 2005;
25(9):
2192 - 2203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fellin and G. Carmignoto
Neurone-to-astrocyte signalling in the brain represents a distinct multifunctional unit
J. Physiol.,
August 15, 2004;
559(1):
3 - 15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Angulo, A. S. Kozlov, S. Charpak, and E. Audinat
Glutamate Released from Glial Cells Synchronizes Neuronal Activity in the Hippocampus
J. Neurosci.,
August 4, 2004;
24(31):
6920 - 6927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Zhang, M. Fukuda, E. Van Bockstaele, O. Pascual, and P. G. Haydon
Synaptotagmin IV regulates glial glutamate release
PNAS,
June 22, 2004;
101(25):
9441 - 9446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Zhang, T. Pangrsic, M. Kreft, M. Krzan, N. Li, J.-Y. Sul, M. Halassa, E. Van Bockstaele, R. Zorec, and P. G. Haydon
Fusion-related Release of Glutamate from Astrocytes
J. Biol. Chem.,
March 26, 2004;
279(13):
12724 - 12733.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Montana, Y. Ni, V. Sunjara, X. Hua, and V. Parpura
Vesicular Glutamate Transporter-Dependent Glutamate Release from Astrocytes
J. Neurosci.,
March 17, 2004;
24(11):
2633 - 2642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-s. Liu, Q. Xu, G. Arcuino, J. Kang, and M. Nedergaard
From The Cover: Astrocyte-mediated activation of neuronal kainate receptors
PNAS,
March 2, 2004;
101(9):
3172 - 3177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Todd, C. A. B. Slatter, and D. W. Ali
Activation of Ionotropic Glutamate Receptors on Peripheral Axons of Primary Motoneurons Mediates Transmitter Release at the Zebrafish NMJ
J Neurophysiol,
February 1, 2004;
91(2):
828 - 840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Fiacco and K. D. McCarthy
Intracellular Astrocyte Calcium Waves In Situ Increase the Frequency of Spontaneous AMPA Receptor Currents in CA1 Pyramidal Neurons
J. Neurosci.,
January 21, 2004;
24(3):
722 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krzan, M. Stenovec, M. Kreft, T. Pangrsic, S. Grilc, P. G. Haydon, and R. Zorec
Calcium-Dependent Exocytosis of Atrial Natriuretic Peptide from Astrocytes
J. Neurosci.,
March 1, 2003;
23(5):
1580 - 1583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Duan, C. M. Anderson, E. C. Keung, Y. Chen, Y. Chen, and R. A. Swanson
P2X7 Receptor-Mediated Release of Excitatory Amino Acids from Astrocytes
J. Neurosci.,
February 15, 2003;
23(4):
1320 - 1328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Coco, F. Calegari, E. Pravettoni, D. Pozzi, E. Taverna, P. Rosa, M. Matteoli, and C. Verderio
Storage and Release of ATP from Astrocytes in Culture
J. Biol. Chem.,
January 3, 2003;
278(2):
1354 - 1362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Aguado, J. F. Espinosa-Parrilla, M. A. Carmona, and E. Soriano
Neuronal Activity Regulates Correlated Network Properties of Spontaneous Calcium Transients in Astrocytes In Situ
J. Neurosci.,
November 1, 2002;
22(21):
9430 - 9444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Fremeau Jr., J. Burman, T. Qureshi, C. H. Tran, J. Proctor, J. Johnson, H. Zhang, D. Sulzer, D. R. Copenhagen, J. Storm-Mathisen, et al.
The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate
PNAS,
October 29, 2002;
99(22):
14488 - 14493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Fields and B. Stevens-Graham
NEUROSCIENCE: New Insights into Neuron-Glia Communication
Science,
October 18, 2002;
298(5593):
556 - 562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Baker, Z.-X. Xi, H. Shen, C. J. Swanson, and P. W. Kalivas
The Origin and Neuronal Function of In Vivo Nonsynaptic Glutamate
J. Neurosci.,
October 15, 2002;
22(20):
9134 - 9141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Amzica and M. Massimini
Glial and Neuronal Interactions during Slow Wave and Paroxysmal Activities in the Neocortex
Cereb Cortex,
October 1, 2002;
12(10):
1101 - 1113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Araque, E. D. Martin, G. Perea, J. I. Arellano, and W. Buno
Synaptically Released Acetylcholine Evokes Ca2+ Elevations in Astrocytes in Hippocampal Slices
J. Neurosci.,
April 1, 2002;
22(7):
2443 - 2450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Amzica, M. Massimini, and A. Manfridi
Spatial Buffering during Slow and Paroxysmal Sleep Oscillations in Cortical Networks of Glial Cells In Vivo
J. Neurosci.,
February 1, 2002;
22(3):
1042 - 1053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Nett, S. H. Oloff, and K. D. McCarthy
Hippocampal Astrocytes In Situ Exhibit Calcium Oscillations That Occur Independent of Neuronal Activity
J Neurophysiol,
January 1, 2002;
87(1):
528 - 537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-X. Xi, D. A. Baker, H. Shen, D. S. Carson, and P. W. Kalivas
Group II Metabotropic Glutamate Receptors Modulate Extracellular Glutamate in the Nucleus Accumbens
J. Pharmacol. Exp. Ther.,
January 1, 2002;
300(1):
162 - 171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Swanson, D. A. Baker, D. Carson, P. F. Worley, and P. W. Kalivas
Repeated Cocaine Administration Attenuates Group I Metabotropic Glutamate Receptor-Mediated Glutamate Release and Behavioral Activation: A Potential Role for Homer
J. Neurosci.,
November 15, 2001;
21(22):
9043 - 9052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mazzanti, J.-Y. Sul, and P. G. Haydon
Book Review: Glutamate on Demand: Astrocytes as a Ready Source
Neuroscientist,
October 1, 2001;
7(5):
396 - 405.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vesce, P. Bezzi, and A. Volterra
Synaptic Transmission with the Glia
Physiology,
August 1, 2001;
16(4):
178 - 184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nagler, D. H Mauch, and F. W Pfrieger
Glia-derived signals induce synapse formation in neurones of the rat central nervous system
J. Physiol.,
June 15, 2001;
533(3):
665 - 679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yamada, M. Otsuka, M. Hayashi, S. Nakatsuka, K. Hamaguchi, A. Yamamoto, and Y. Moriyama
Ca2+-Dependent Exocytosis of L-Glutamate by {alpha}TC6, Clonal Mouse Pancreatic {alpha}-Cells
Diabetes,
May 1, 2001;
50(5):
1012 - 1020.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Pasti, M. Zonta, T. Pozzan, S. Vicini, and G. Carmignoto
Cytosolic Calcium Oscillations in Astrocytes May Regulate Exocytotic Release of Glutamate
J. Neurosci.,
January 15, 2001;
21(2):
477 - 484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Parpura and P. G. Haydon
From the Cover: Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons
PNAS,
July 18, 2000;
97(15):
8629 - 8634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nakatsuka, M. Hayashi, A. Muroyama, M. Otsuka, S. Kozaki, H. Yamada, and Y. Moriyama
D-Aspartate Is Stored in Secretory Granules and Released through a Ca2+-dependent Pathway in a Subset of Rat Pheochromocytoma PC12 Cells
J. Biol. Chem.,
July 6, 2001;
276(28):
26589 - 26596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Varma, G. C. Carlson, C. Ledent, and B. E. Alger
Metabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus
J. Neurosci.,
December 15, 2001;
21(24):
RC188 - RC188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Su, D. B. Kintner, and D. Sun
Contribution of Na+-K+-Cl- cotransporter to high-[K+]o- induced swelling and EAA release in astrocytes
Am J Physiol Cell Physiol,
May 1, 2002;
282(5):
C1136 - C1146.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|